immatics biotechnologies GmbH
Anti-WT1/HLA-specific antibodies
Last updated:
Abstract:
The present invention relates to antibodies or fragments thereof binding to human WT1/HLA. In particular, the present invention relates to antibodies or fragments thereof that have combined improved and/or beneficial properties, and are therefore suited for clinical development.
Status:
Grant
Type:
Utility
Filling date:
7 Oct 2016
Issue date:
17 Nov 2020